NADP+ -dependent IDH1 R132 mutation and its relevance for glioma patient survival.
Baldewpersad Tewarie NM, Burgers IA, Dawood Y, den Boon HC, den Brok MG, Klunder JH, Koopmans KB, Rademaker E, van den Broek HB, van den Bersselaar SM, Witjes JJ, Van Noorden CJ, Atai NA.
Baldewpersad Tewarie NM, et al. Among authors: den boon hc, den brok mg.
Med Hypotheses. 2013 Jun;80(6):728-31. doi: 10.1016/j.mehy.2013.02.022. Epub 2013 Mar 29.
Med Hypotheses. 2013.
PMID: 23541771